MedTrace Logo

Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison

NCT00356070 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-04-28

No results posted yet for this study

Summary

The treatment of ADHD in jail will help the prisoners in their rehabilitation process

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Strattera

Sponsors & Collaborators

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Roger Almvik, md phd · St. Olavs Hospital, Departement of forensic psychiatry, Brøset

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2006-12-31
Completion
2006-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00356070 on ClinicalTrials.gov